Evidence map›Paper›PMID 36273067›Full record

ArticleIntensive care medicine experimental2022

Hemodynamic management of acute brain injury caused by cerebrovascular diseases: a survey of the European Society of Intensive Care Medicine.

Antonio Messina, Federico Villa, Giulia Lionetti, Laura Galarza, Geert Meyfroidt, Mathieu van der Jagt, Xavier Monnet, Paolo Pelosi, Maurizio Cecconi, Chiara Robba

Open access · goldAbstract read
In one paragraph

Article in Intensive care medicine experimental, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Eight rules for the haemodynamic management of traumatic brain-injured patients.European journal of anaesthesiology and intensive care · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Antonio MessinaDepartment of Anesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital - IRCCS, Humanitas University, via Alessandro Manzoni 56, 20089, Rozzano, Milan, Italy. antonio.messina@humanitas.it.ORCID http://orcid.org/0000-0002-9744-1659
Federico VillaDepartment of Anesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital - IRCCS, Humanitas University, via Alessandro Manzoni 56, 20089, Rozzano, Milan, Italy.
Giulia LionettiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Laura GalarzaDepartment of Intensive Care, Hospital General Universitario de Castellon, Castellon de la Plana, Spain.
Geert MeyfroidtDepartment and Laboratory of Intensive Care Medicine, University Hospitals Leuven and KU Leuven, Louvain, Belgium.
Mathieu van der JagtDepartment of Intensive Care Adults and Erasmus MC Stroke Center, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.
Xavier MonnetParis-Saclay University, AP-HP, Medical Intensive Care Unit, Bicêtre Hospital, DMU CORREVE, Inserm UMR S_999, FHU SEPSIS, CARMAS Research Team, Le Kremlin-Bicêtre, France.
Paolo PelosiAnaesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.
Maurizio CecconiDepartment of Anesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital - IRCCS, Humanitas University, via Alessandro Manzoni 56, 20089, Rozzano, Milan, Italy.
Chiara RobbaAnaesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.
Humanitas University · ITOspedale Policlinico San Martino · ITErasmus MC · NLHospital General Universitari de Castelló · ESInserm · FRIRCCS Humanitas Research Hospital · ITUniversitair Ziekenhuis Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal hemodynamic targets and management of patients with acute brain injury are not completely elucidated, but recent evidence points to important impact on clinical outcomes. We performed an international survey with the aim to investigate the practice in the hemodynamic targets, monitoring, and management of patients with acute ischemic stroke (AIS), intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH).

methodsThis survey was endorsed by the European Society of Intensive Care (ESICM). An electronic questionnaire of 76 questions divided in 4 sections (general information, AIS, ICH, SAH specific questions) was available between January 2022 to March 2022 on the ESICM website.

resultsOne hundred fifty-four healthcare professionals from 36 different countries and at least 98 different institutions answered the survey. Routine echocardiography is routinely performed in 37% of responders in AIS, 34% in ICH and 38% in SAH. Cardiac output monitoring is used in less than 20% of cases by most of the responders. Cardiovascular complications are the main reason for using advanced hemodynamic monitoring, and norepinephrine is the most common drug used to increase arterial blood pressure. Most responders target fluid balance to neutral (62% in AIS, 59% in ICH,44% in SAH), and normal saline is the most common fluid used. Large variability was observed regarding the blood pressure targets.

conclusionsHemodynamic management and treatment in patients with acute brain injury from cerebrovascular diseases vary largely in clinical practice. Further research is required to provide clear guidelines to physicians for the hemodynamic optimization of this group of patients.

Indexed as

Acute ischemic strokeHemodynamic managementIntracranial hemorrhageSubarachnoid hemorrhage

Identifiers

PMID36273067
PMCPMC9588138
OpenAlexW4307134685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.